EP3829618
ANTIGEN PURIFICATION METHOD
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
30.7.2019:
16.7.2025:
19779554.5
:
29.7.2039:
15.11.2025
:
ANTIGEN PURIFICATION METHOD
30.7.2019
16.7.2025
15.11.2025
:
GlaxoSmithKline Biologicals SA:
Rue de l'Institut, 89, 1330 Rixensart, BE
:
BAKSHI, Kunal:
Rockville, Maryland 20850, US
:
BUGNO, Marcin Krzysztof:
Rockville, Maryland 20850, US
:
CHANDRAMOULI, Sumana:
Rockville, Maryland 20850, US
:
TYSON, Matthew Albert:
Wendell, North Carolina 27591, US
:
WANG, Zihao:
Rockville, Maryland 20850, US
:
WILSON, Mark Jonathan:
Rockville, Maryland 20850, US
:
201862712280 P:
31.7.2018:
US
:
IB2019056501:
30.7.2019
:
A61K 38/10, A61K 39/00, A61K 39/155, A61P 31/14, A61P 43/00, C07K 14/135, C12N 15/62